ARTICLE | Company News
Management tracks
March 10, 2017 4:00 PM UTC
Orphan disease company Dynacure S.A.S. (Illkirch-Graffenstaden, France) named Stephane van Rooijen CEO and Frederic Legros COO. van Rooijen was CEO at Confo Therapeutics N.V. (Brussels, Belgium). Legros was VP and corporate head of business development at Valneva SE (Euronext:VLA; VSE:VLA).
Epigenetics company Epizyme Inc. (NASDAQ:EPZM) said President of Research and CSO Robert Copeland will retire next quarter...